USA - NYSE:PRGO - IE00BGH1M568 - Common Stock
PRGO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of PRGO while its profitability can be described as average. PRGO is valued quite cheap, while showing a decent growth score. This is a good combination! PRGO also has an excellent dividend rating.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.8% | ||
ROE | -1.8% | ||
ROIC | 3.64% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 9.55% | ||
PM (TTM) | N/A | ||
GM | 35.73% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.81 | ||
Debt/FCF | 14.23 | ||
Altman-Z | 0.74 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.32 | ||
Quick Ratio | 1.24 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.54 | ||
Fwd PE | 6.86 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 11.75 | ||
EV/EBITDA | 8.33 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 5.39% |
21.93
+0.23 (+1.06%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 5.39% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.54 | ||
Fwd PE | 6.86 | ||
P/S | 0.7 | ||
P/FCF | 11.75 | ||
P/OCF | 8.24 | ||
P/B | 0.67 | ||
P/tB | N/A | ||
EV/EBITDA | 8.33 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -0.8% | ||
ROE | -1.8% | ||
ROCE | 4.61% | ||
ROIC | 3.64% | ||
ROICexc | 3.83% | ||
ROICexgc | 13.21% | ||
OM | 9.55% | ||
PM (TTM) | N/A | ||
GM | 35.73% | ||
FCFM | 5.93% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.81 | ||
Debt/FCF | 14.23 | ||
Debt/EBITDA | 4.87 | ||
Cap/Depr | 33.3% | ||
Cap/Sales | 2.53% | ||
Interest Coverage | 250 | ||
Cash Conversion | 49.35% | ||
Profit Quality | N/A | ||
Current Ratio | 2.32 | ||
Quick Ratio | 1.24 | ||
Altman-Z | 0.74 |